Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Vontobel Holding Ltd.

Vontobel Holding Ltd. decreased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 47.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,981 shares of the company’s stock after selling 3,647 shares during the quarter. Vontobel Holding Ltd.’s holdings in Henry Schein were worth $275,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the company. Blue Trust Inc. raised its holdings in Henry Schein by 157.0% during the third quarter. Blue Trust Inc. now owns 2,393 shares of the company’s stock worth $174,000 after purchasing an additional 1,462 shares in the last quarter. Assenagon Asset Management S.A. raised its holdings in Henry Schein by 772.1% during the third quarter. Assenagon Asset Management S.A. now owns 254,580 shares of the company’s stock worth $18,559,000 after purchasing an additional 225,388 shares in the last quarter. Cromwell Holdings LLC raised its holdings in Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its holdings in Henry Schein by 32.5% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,204 shares of the company’s stock worth $894,000 after purchasing an additional 2,992 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale raised its holdings in Henry Schein by 13.1% during the third quarter. DekaBank Deutsche Girozentrale now owns 953,792 shares of the company’s stock worth $69,498,000 after purchasing an additional 110,270 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on HSIC shares. Jefferies Financial Group raised their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the company from $69.00 to $84.00 in a report on Monday, January 6th. Mizuho began coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Wells Fargo & Company began coverage on shares of Henry Schein in a report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price on the stock. Eight research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $80.09.

Henry Schein Price Performance

Shares of NASDAQ HSIC opened at $77.24 on Friday. The firm has a market capitalization of $9.63 billion, a P/E ratio of 31.79, a PEG ratio of 2.12 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63. The company’s fifty day moving average is $74.14 and its two-hundred day moving average is $72.21.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.